November, 2025 - Microbiome Times Magazine

Ferring Presents New Data Analyses for REBYOTA®

November 4, 2025 Microbiome Times

Ferring Pharmaceuticals shared an oral presentation last month detailing microbiome restoration from the Phase 3b CDI-SCOPE study among patients with recurrent C. difficile (C. diff) infection (CDI) who received REBYOTA® (fecal microbiota, live – jslm). This research was […]

Ascribe Bio Closes $12 Million Series A Financing to Advance Next-Generation Natural Crop Protection

November 3, 2025 Microbiome Times

Ascribe Bio, an innovator in natural crop protection, announced the closing of an oversubscribed $12 million Series A financing round, co-led by Corteva, through its Corteva Catalyst platform, and Acre Venture Partners. The financing also included participation […]